Finance

Lists
ACET:NASDAQ
Adicet Bio Inc
6,47 $
-0,46%
(-0,030) 1D
6,49 $
+0,31% (+0,020)
After hours
Closed: 5 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACET...
Open
6,53 $
High
6,69 $
Low
6,28 $
Mkt. cap
60,57 մլն
Avg. vol.
246,64 հզր
Volume
152,65 հզր
52-wk high
17,44 $
52-wk low
6,01 $
EPS
-13,02 $
Beta
1,62
Shares outstanding
9,36 մլն
No. of employees
102
Open
6,53 $
High
6,69 $
Low
6,28 $
Mkt. cap
60,57 մլն
Avg. vol.
246,64 հզր
Volume
152,65 հզր
52-wk high
17,44 $
52-wk low
6,01 $
EPS
-13,02 $
Beta
1,62
Shares outstanding
9,36 մլն
No. of employees
102
News stories
From web sources and news partners
About Adicet Bio Inc
CEO-
Employees102
Founded2014
HeadquartersԲոստոն, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiteadicetbio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ACET in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ACET in the last 3 months.
Highest
Current 6,47 $
34,00 $ (+425,50%)
Average
25,00 $ (+286,40%)
Lowest
18,00 $ (+178,21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Driscoll
Wedbush
Buy
Reiterated
28,00 $
+332,8%
09/29/2026
John Newman
Canaccord Genuity
Buy
Maintained
18,00 $
+178,2%
09/29/2026
Boris Peaker
JonesTrading
Buy
Maintained
20,00 $
+209,1%
09/28/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
34,00 $
+425,5%
09/29/2026
Unknown Analyst
Wedbush
Buy
Reiterated
25,00 $
+286,4%
08/06/2026
Anthea Li
Jefferies
Buy
Initiated
19,00 $
+193,7%
05/04/2026
Soumit Roy
JonesTrading
Buy
Maintained
20,00 $
+209,1%
04/06/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
-
-
03/16/2026
Yatin Suneja
Guggenheim
Buy
Maintained
100,00 $
+1 445,6%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22,85 մլն
25,04 մլն
17,49 մլն
18,45 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,10 մլն
6,85 մլն
4,08 մլն
3,85 մլն
Operating expense
27,95 մլն
31,89 մլն
21,57 մլն
22,30 մլն
Total operating expenses
27,95 մլն
31,89 մլն
21,57 մլն
22,30 մլն
Operating income
-27,95 մլն
-31,89 մլն
-21,57 մլն
-22,30 մլն
Other non operating income
-64,00 հզր
-130,00 հզր
7,00 հզր
-60,00 հզր
EBT including unusual items
-26,86 մլն
-30,52 մլն
-20,24 մլն
-21,22 մլն
EBT excluding unusual items
-26,86 մլն
-30,52 մլն
-20,24 մլն
-21,22 մլն
Income tax expense
-
-
-
143,00 հզր
Effective tax rate
-
-
-
-0,67%
Other operating expenses
-
-
-
-
Net income
-26,86 մլն
-30,52 մլն
-20,24 մլն
-21,36 մլն
Net profit margin
-
-
-
-
Earnings per share
-4,64
-2,94
-1,88
-1,99
Interest and investment income
1,17 մլն
1,52 մլն
1,34 մլն
1,17 մլն
Interest expense
-12,00 հզր
-24,00 հզր
-23,00 հզր
-22,00 հզր
Net interest expenses
1,16 մլն
1,50 մլն
1,32 մլն
1,15 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-26,38 մլն
-30,41 մլն
-20,23 մլն
-21,10 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps